«

»

AI pathology firm Proscia nets $37M investment

Proscia, a company that uses artificial intelligence to treat and research cancer, has raised $37 million in series C funding.

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive